Holistic, INC
Holistic, INC was paid $7.98M by Medicaid between Apr 2018 and Nov 2022, across 38 billing codes. Its largest line is G0482, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed — 22% of everything it billed.
CHARLESTON, WV 25304
Next to other Medical Specialty Clinic/Center providers in West Virginia
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 23,739 | $994K | |
| 2019 | 22,160 | $968K | |
| 2020 | 64,421 | $2.90M | |
| 2021 | 48,731 | $2.36M | |
| 2022 | 17,793 | $755K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 22% | 12,745 | 7,538 | $1.74M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 16% | 28,011 | 12,281 | $1.30M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 16% | 27,445 | 12,278 | $1.28M |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 15% | 28,552 | 11,045 | $1.21M |
| 82075 | 5.3% | 14,415 | 6,440 | $425K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | 5.0% | 10,659 | 4,149 | $401K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.4% | 5,579 | 4,372 | $352K |
| 99406 | 3.4% | 16,540 | 8,215 | $272K | |
| 99401 | 2.8% | 7,642 | 3,898 | $226K | |
| 99407 | 1.9% | 4,656 | 3,866 | $150K | |
| 99402 | 1.7% | 2,854 | 2,175 | $139K | |
| 81025 | 1.4% | 6,522 | 2,984 | $114K |
26 more codes
| 86328 | 1.2% | 2,621 | $99K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 734 | $73K |
| 90863 | <1% | 1,738 | $30K | |
| 80305 | <1% | 793 | $24K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 1,309 | $24K |
| 90837 | Psychotherapy session, about an hour | <1% | 274 | $23K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 381 | $19K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 204 | $12K |
| 93000 | <1% | 615 | $9K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 114 | $7K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 219 | $7K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 85 | $6K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 73 | $6K |
| 99385 | <1% | 97 | $5K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 99 | $5K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | <1% | 608 | $5K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 283 | $4K |
| H0031 | Mental health assessment, by non-physician | <1% | 21 | $3K |
| 93922 | <1% | 56 | $3K | |
| 94010 | <1% | 118 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 392 | $2K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 148 | $2K |
| 90686 | <1% | 37 | $623.96 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 89 | $510.65 |
| 90658 | <1% | 53 | $438.02 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 63 | $125.01 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.